Stifel Reiterates Buy Rating on Alto Neuroscience (ANRO) as co on track for ph2b TRD study for ALTO-207
Go back to Stifel Reiterates Buy Rating on Alto Neuroscience (ANRO) as co on track for ph2b TRD study for ALTO-207| (NYSE: ANRO) | Delayed: 32.14 -0.16 (0.5%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $32.30 | 52 Week High | $ | |||
| Open | $31.77 | 52 Week Low | $ | |||
| Day High | $32.29 | P/E | N/A | |||
| Day Low | $29.88 | EPS | $ | |||
| Volume | 874,491 | |||||
